The Fellow on Call: The Heme/Onc Podcast Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
Dec 11, 2024
Dr. Amar Kelkar, a hematology and oncology expert from Dana-Farber Cancer Institute, delves into allogeneic transplant options for acute myeloid leukemia (AML). He discusses the various conditioning regimens and how to choose the best one for patients. The conversation also highlights the critical role of measurable residual disease testing and maintenance therapies. Kelkar sheds light on graft-versus-host disease and recent advancements in haploidentical transplants, addressing racial disparities in transplant outcomes for better equity.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 5min
Navigating AML Treatment Protocols
05:02 • 10min
Understanding Graft-Versus-Host Disease and Treatment Advances
14:48 • 4min
Advancements in Haploidentical Transplant Techniques
18:35 • 2min
Haplotransplant Considerations and Racial Disparities in Transplant Outcomes
20:52 • 5min